102 related articles for article (PubMed ID: 15478327)
21. Injury rate and socioeconomic costs resulting from sports injuries in Flanders: data derived from sports insurance statistics 2003.
Cumps E; Verhagen E; Annemans L; Meeusen R
Br J Sports Med; 2008 Sep; 42(9):767-72. PubMed ID: 18048438
[TBL] [Abstract][Full Text] [Related]
22. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
23. [Projections of future resource use and the costs of asthma and COPD in the Netherlands].
Hoogendoorn M; Feenstra TL; Rutten-van Mölken MP
Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1243-50. PubMed ID: 16796176
[TBL] [Abstract][Full Text] [Related]
24. [The costs of a multiple sclerosis relapse in Catalonia (Spain)].
Casado V; Martinez-Yelamos S; Martinez-Yelamos A; Carmona O; Alonso L; Romero L; Moral E; Arbizu T
Neurologia; 2006 Sep; 21(7):341-7. PubMed ID: 16977554
[TBL] [Abstract][Full Text] [Related]
25. Estimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in France.
Tilleul P; LaFuma A; Colin X; Ozier Y
Clin Appl Thromb Hemost; 2006 Oct; 12(4):473-84. PubMed ID: 17000893
[TBL] [Abstract][Full Text] [Related]
26. Indirect costs of myocardial infarction in Portugal.
Timóteo AT; Gouveia M; Soares C; Cruz Ferreira R
Rev Port Cardiol (Engl Ed); 2020 May; 39(5):245-251. PubMed ID: 32505635
[TBL] [Abstract][Full Text] [Related]
27. Burden of illness imposed by severe sepsis in Germany.
Schmid A; Burchardi H; Clouth J; Schneider H
Eur J Health Econ; 2002; 3(2):77-82. PubMed ID: 15609133
[TBL] [Abstract][Full Text] [Related]
28. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
Sasser AC; Rousculp MD; Birnbaum HG; Oster EF; Lufkin E; Mallet D
Womens Health Issues; 2005; 15(3):97-108. PubMed ID: 15894195
[TBL] [Abstract][Full Text] [Related]
29. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
Lee IH; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yeh LL; Cheng SH; Chu CL
Psychiatry Res; 2008 Apr; 158(3):306-15. PubMed ID: 18243334
[TBL] [Abstract][Full Text] [Related]
30. Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.
Willich SN; Müller-Nordhorn J; Sonntag F; Völler H; Meyer-Sabellek W; Wegscheider K; Windler E; Katus H
Am Heart J; 2004 Dec; 148(6):1060-7. PubMed ID: 15632894
[TBL] [Abstract][Full Text] [Related]
31. Socio-economic cost and health-related quality of life of burn victims in Spain.
Sanchez JL; Bastida JL; Martínez MM; Moreno JM; Chamorro JJ
Burns; 2008 Nov; 34(7):975-81. PubMed ID: 18472221
[TBL] [Abstract][Full Text] [Related]
32. The socioeconomic costs of mental illness in Spain.
Oliva-Moreno J; López-Bastida J; Montejo-González AL; Osuna-Guerrero R; Duque-González B
Eur J Health Econ; 2009 Oct; 10(4):361-9. PubMed ID: 19031056
[TBL] [Abstract][Full Text] [Related]
33. Costs of metabolic syndrome-related diseases induced by obesity in Taiwan.
Fu T; Wen T; Yeh P; Chang H
Obes Rev; 2008 Mar; 9 Suppl 1():68-73. PubMed ID: 18307702
[TBL] [Abstract][Full Text] [Related]
34. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
35. Costs of heart disease and risk behaviour: implications for expenditure on prevention.
Kruse M; Davidsen M; Madsen M; Gyrd-Hansen D; Sørensen J
Scand J Public Health; 2008 Nov; 36(8):850-6. PubMed ID: 19004902
[TBL] [Abstract][Full Text] [Related]
36. Economic burden of knee and hip osteoarthritis in Spain.
Loza E; Lopez-Gomez JM; Abasolo L; Maese J; Carmona L; Batlle-Gualda E;
Arthritis Rheum; 2009 Feb; 61(2):158-65. PubMed ID: 19177521
[TBL] [Abstract][Full Text] [Related]
37. The public health implications of asthma.
Bousquet J; Bousquet PJ; Godard P; Daures JP
Bull World Health Organ; 2005 Jul; 83(7):548-54. PubMed ID: 16175830
[TBL] [Abstract][Full Text] [Related]
38. Cost of cardiovascular diseases in the United Kingdom.
Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
[TBL] [Abstract][Full Text] [Related]
39. Direct medical costs of bronchiolitis hospitalizations in the United States.
Pelletier AJ; Mansbach JM; Camargo CA
Pediatrics; 2006 Dec; 118(6):2418-23. PubMed ID: 17142527
[TBL] [Abstract][Full Text] [Related]
40. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
